DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: Insights into CpG island methylator phenotype in T-ALL

Leukemia

Volumn 26, Issue 2, 2012, Pages 367-371

  Kraszewska, M D ^a   Dawidowska, M ^a   Larmonie, N S D ^b   Kosmalska, M ^a   Sedek L ^c   Szczepaniak, M ^a,d   Grzeszczak, W ^c   Langerak, A W ^b   Szczepanski T ^c   Witt, M ^a,d  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 2; ASPP1 PROTEIN; BCL11B PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FBXW7 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATS1 PROTEIN; NES1 PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; PHF6 PROTEIN; PROTEIN; PROTEIN KINASE SYK; PROTEIN P73; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN; WIF1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER PATIENT; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYMOCYTE;

EID: 84856728415     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.208     Document Type: Letter

References (15)

1. Dawidowska M, Derwich K, Szczepanski T, Jolkowska J, van der Velden VH, Wachowiak J et al. Pattern of immunoglobulin and T-cell receptor (Ig/TCR) gene rearrangements in Polish pediatric acute lymphoblastic leukemia patients-implications for RQ-PCRbased assessment of minimal residual disease. Leuk Res 2006; 30: 1119-1125. (Pubitemid 44037082)
2. Dawidowska M, Jolkowska J, Szczepanski T, Derwich K, Wachowiak J, Witt M. Implementation of the standard strategy for identification of Ig/TCR targets for minimal residual disease diagnostics in B-cell precursor ALL pediatric patients: polish experience. Arch Immunol Ther Exp (Warsz) 2008; 56: 409-418.
3. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 24: 132-138. (Pubitemid 30094712)
4. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 2005; 23: 7043-7049.
5. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999; 96: 8681-8686. (Pubitemid 29354851)
6. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38: 787-793. (Pubitemid 43980599)
7. Kleppe M, Lahortiga I, El Chaar T, De Keersmaecker K, Mentens N, Graux C et al. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nat Genet 2010; 42: 530-535.
8. Van Vlierberghe P, Pieters R, Beverloo HB, Meijerink JP. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol 2008; 43: 153-168.
9. Roman-Gomez J, Jimenez-Velasco A, Barrios M, Prosper F, Heiniger A, Torres A et al. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancerrelated genes. Leuk Lymphoma 2007; 48: 1269-1282. (Pubitemid 47079354)
10. Roman-Gomez J, Jimenez-Velasco A, Castillejo JA, Agirre X, Barrios M, Navarro G et al. Promoter hypermethylation of cancerrelated genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004; 104: 2492-2498. (Pubitemid 39331852)
11. Udayakumar AM, Pathare AV, Dennison D, Praeburn JA. Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia. J Appl Genet 2009; 50: 73-76.
12. Terriou L, Ben Abdelali R, Roumier C, Lhermitte L, de Vos J, Cornillet P et al. C/EBPA methylation is common in T-ALL but not in M0 AML. Blood 2009; 113: 1864-1866; author reply 1866.
13. Goel A, Li MS, Nagasaka T, Shin SK, Fuerst F, Ricciardiello L et al. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology 2006; 130: 1950-1961. (Pubitemid 43816967)
14. Karpinski P, Sasiadek MM, Blin N. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers. J Appl Genet 2008; 49: 1-10. (Pubitemid 351272295)
15. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J et al. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 1997; 57: 832-836. (Pubitemid 27098004)